3//SEC Filing
Palmetto Partners, Ltd. 3
Accession 0000908662-18-000168
CIK 0001346302other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 7:31 PM ET
Size
21.9 KB
Accession
0000908662-18-000168
Insider Transaction Report
Form 3
Palmetto Partners 2014, LP
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (581,992 underlying)Series B Preferred Stock
→ Common Stock (447,686 underlying)Stock Option (right to buy)
Exercise: $1.98Exp: 2025-02-25→ Common Stock (11,228 underlying)Series A Preferred Stock
→ Common Stock (930,383 underlying)
Palmetto Partners, Ltd.
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (930,383 underlying)Stock Option (right to buy)
Exercise: $1.98Exp: 2025-02-25→ Common Stock (11,228 underlying)Series B Preferred Stock
→ Common Stock (581,992 underlying)Series B Preferred Stock
→ Common Stock (447,686 underlying)
Palmetto Partners 2015, LP
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (930,383 underlying)Series B Preferred Stock
→ Common Stock (447,686 underlying)Series B Preferred Stock
→ Common Stock (581,992 underlying)Stock Option (right to buy)
Exercise: $1.98Exp: 2025-02-25→ Common Stock (11,228 underlying)
Footnotes (5)
- [F1]The securities are owned by Palmetto Partners 2014, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2015, LP.
- [F2]The securities are owned by Palmetto Partners 2015, LP., who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2014, LP.
- [F3]The securities are owned by Palmetto Partners, Ltd., who is a member of a group with Palmetto Partners 2014, LP and Palmetto Partners 2015, LP.
- [F4]Each share of preferred stock is convertible on a 1.78112-for-1 basis into Common Stock at any time at the election of the Reporting Persons and will automatically convert upon the closing of the Issuer's initial public offering into the number of shares of the Issuer's Common Stock shown in column 3 without payment or further consideration. The shares have no expiration date.
- [F5]As of the date of this Report, the Stock Option is fully vested.
Issuer
XERIS PHARMACEUTICALS INC
CIK 0001346302
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0001744226
Filing Metadata
- Form type
- 3
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 7:31 PM ET
- Size
- 21.9 KB